Pseudomonas aeruginosa co-opts host antibiotic metabolism by pyocyanin induction of cytochrome P450 enzymes.
bioRxiv.
2026 Jul 27;. doi: 10.64898/2026.07.25.740721. PubMed PMID:
42619675; PubMed Central PMCID:
PMC13483869.
Biotransformation research advances-2025 year in review.
Drug Metab Rev.
2026 Aug;58(3):306-354. doi: 10.1080/03602532.2026.2666155. Epub 2026 May 25. Review. PubMed PMID:
42059906.
A CYP3A7 metabolically competent human induced pluripotent stem cell-derived hepatocyte-like cell (hHLC(3A7)) model for drug safety assessment in the newborn.
Drug Metab Dispos.
2026 Jun;54(6):100314. doi: 10.1016/j.dmd.2026.100314. Epub 2026 Apr 30. PubMed PMID:
42224858.
New Mechanistic Evidence for Perfluorodecanoic Acid (PFDA) Teratogenicity via CYP26A1-Mediated Retinoic Acid Metabolism and Signaling.
Chem Res Toxicol.
2026 Apr 20;39(4):566-583. doi: 10.1021/acs.chemrestox.5c00468. Epub 2026 Mar 30. PubMed PMID:
41910604; PubMed Central PMCID:
PMC13100982.
Novel emerging cell and organoid systems for the study of drug metabolism and toxicity in humans.
Drug Metab Dispos.
2025 Dec;53(12):100188. doi: 10.1016/j.dmd.2025.100188. Epub 2025 Oct 22. Review. PubMed PMID:
41252796; PubMed Central PMCID:
PMC13095430.
The anti-inflammatory drug celecoxib is metabolized by Pseudomonas aeruginosa CYP107S1 in vitro and in vivo.
Drug Metab Dispos.
2025 Dec;53(12):100184. doi: 10.1016/j.dmd.2025.100184. Epub 2025 Oct 21. PubMed PMID:
41237685; PubMed Central PMCID:
PMC13095469.
Mechanistic insights into human carboxylesterase 2 (CES2) inhibition by the CES1 prodrug substrate remdesivir.
Drug Metab Dispos.
2025 Oct;53(10):100158. doi: 10.1016/j.dmd.2025.100158. Epub 2025 Sep 8. PubMed PMID:
41061301; PubMed Central PMCID:
PMC13095431.
Comparison of the CYP3A Selective Inhibitors CYP3cide, Clobetasol, and Azamulin for Their Potential to Distinguish CYP3A7 Activity in the Presence of CYP3A4/5.
Drug Metab Dispos.
2024 Oct 16;52(11):1224-1233. doi: 10.1124/dmd.124.001598. PubMed PMID:
38702193; PubMed Central PMCID:
PMC11495666.
Drug metabolism of ciprofloxacin, ivacaftor, and raloxifene by Pseudomonas aeruginosa cytochrome P450 CYP107S1.
J Biol Chem.
2024 Aug;300(8):107594. doi: 10.1016/j.jbc.2024.107594. Epub 2024 Jul 18. PubMed PMID:
39032655; PubMed Central PMCID:
PMC11382314.
HCV Antiviral Drugs Have the Potential to Adversely Perturb the Fetal-Maternal Communication Axis through Inhibition of CYP3A7 DHEA-S Oxidation.
Drug Metab Dispos.
2024 May 16;52(6):516-525. doi: 10.1124/dmd.123.001434. PubMed PMID:
38267095; PubMed Central PMCID:
PMC11114604.
Correction: Human cytochrome P450 3A7 binding four copies of its native substrate dehydroepiandrosterone 3-sulfate.
J Biol Chem.
2023 Oct;299(10):105283. doi: 10.1016/j.jbc.2023.105283. Epub 2023 Sep 30. PubMed PMID:
37783037; PubMed Central PMCID:
PMC10551884.
Consideration of Nevirapine Analogs To Reduce Metabolically Linked Hepatotoxicity: A Cautionary Tale of the Deuteration Approach.
Chem Res Toxicol.
2023 Oct 16;36(10):1631-1642. doi: 10.1021/acs.chemrestox.3c00192. Epub 2023 Sep 28. PubMed PMID:
37769118; PubMed Central PMCID:
PMC10583834.
Human cytochrome P450 3A7 binding four copies of its native substrate dehydroepiandrosterone 3-sulfate.
J Biol Chem.
2023 Aug;299(8):104993. doi: 10.1016/j.jbc.2023.104993. Epub 2023 Jun 29. PubMed PMID:
37392852; PubMed Central PMCID:
PMC10388207.
Transcriptomics, metabolomics, and in-silico drug predictions for liver damage in young and aged burn victims.
Commun Biol.
2023 Jun 2;6(1):597. doi: 10.1038/s42003-023-04964-2. PubMed PMID:
37268765; PubMed Central PMCID:
PMC10238406.
Per- and polyfluoroalkyl substances (PFAS) inhibit cytochrome P450 CYP3A7 through direct coordination to the heme iron and water displacement.
J Inorg Biochem.
2023 Mar;240:112120. doi: 10.1016/j.jinorgbio.2023.112120. Epub 2023 Jan 4. PubMed PMID:
36638633; PubMed Central PMCID:
PMC10016736.
Cefadroxil Comparable to Cephalexin: Minimum Inhibitory Concentrations among Methicillin-Susceptible Staphylococcus aureus Isolates from Pediatric Musculoskeletal Infections.
Microbiol Spectr.
2022 Aug 31;10(4):e0103922. doi: 10.1128/spectrum.01039-22. Epub 2022 Jun 22. PubMed PMID:
35730963; PubMed Central PMCID:
PMC9431593.
Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (M(pro)) inhibitors.
Bioorg Med Chem Lett.
2022 Jun 15;66:128732. doi: 10.1016/j.bmcl.2022.128732. Epub 2022 Apr 12. PubMed PMID:
35427739; PubMed Central PMCID:
PMC9004148.
Pseudomonas aeruginosa cytochrome P450 CYP168A1 is a fatty acid hydroxylase that metabolizes arachidonic acid to the vasodilator 19-HETE.
J Biol Chem.
2022 Mar;298(3):101629. doi: 10.1016/j.jbc.2022.101629. Epub 2022 Jan 24. PubMed PMID:
35085556; PubMed Central PMCID:
PMC8913318.
<i>Pseudomonas aeruginosa</i> cytochrome P450 CYP168A1 is a fatty acid hydroxylase that metabolizes arachidonic acid to the vasodilator 19-HETE. [Preprint]. 2021 October. doi: 10.1101/2021.10.19.465045.
Characterization of fluorescent probe substrates to develop an efficient high-throughput assay for neonatal hepatic CYP3A7 inhibition screening.
Sci Rep.
2021 Sep 30;11(1):19443. doi: 10.1038/s41598-021-98219-x. PubMed PMID:
34593846; PubMed Central PMCID:
PMC8484451.
Inhibition of CYP3A7 DHEA-S Oxidation by Lopinavir and Ritonavir: An Alternative Mechanism for Adrenal Impairment in HIV Antiretroviral-Treated Neonates.
Chem Res Toxicol.
2021 Apr 19;34(4):1150-1160. doi: 10.1021/acs.chemrestox.1c00028. Epub 2021 Apr 6. PubMed PMID:
33821626; PubMed Central PMCID:
PMC8058764.
Human Fetal Liver Metabolism of Oxycodone Is Mediated by CYP3A7.
AAPS J.
2021 Jan 12;23(1):24. doi: 10.1208/s12248-020-00537-x. PubMed PMID:
33438174; PubMed Central PMCID:
PMC8106324.
Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.
Arch Biochem Biophys.
2019 Sep 30;673:108078. doi: 10.1016/j.abb.2019.108078. Epub 2019 Aug 22. Review. PubMed PMID:
31445893; PubMed Central PMCID:
PMC6739124.
Aqueous synthesis of a small-molecule lanthanide chelator amenable to copper-free click chemistry.
PLoS One.
2019;14(3):e0209726. doi: 10.1371/journal.pone.0209726. eCollection 2019. PubMed PMID:
30917122; PubMed Central PMCID:
PMC6436693.
Ligand-dependent modulation of hOCT1 transport reveals discrete ligand binding sites within the substrate translocation channel.
Biochem Pharmacol.
2018 Oct;156:371-384. doi: 10.1016/j.bcp.2018.08.028. Epub 2018 Aug 20. PubMed PMID:
30138624; PubMed Central PMCID:
PMC6195816.
Digging Deeper into CYP3A Testosterone Metabolism: Kinetic, Regioselectivity, and Stereoselectivity Differences between CYP3A4/5 and CYP3A7.
Drug Metab Dispos.
2017 Dec;45(12):1266-1275. doi: 10.1124/dmd.117.078055. Epub 2017 Oct 6. PubMed PMID:
28986474; PubMed Central PMCID:
PMC5697443.
Advances in the Understanding of Protein-Protein Interactions in Drug Metabolizing Enzymes through the Use of Biophysical Techniques.
Front Pharmacol.
2017;8:521. doi: 10.3389/fphar.2017.00521. eCollection 2017. Review. PubMed PMID:
28848438; PubMed Central PMCID:
PMC5550701.
The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction.
Toxicol Appl Pharmacol.
2016 Aug 1;304:18-29. doi: 10.1016/j.taap.2016.05.001. Epub 2016 May 3. PubMed PMID:
27153767; PubMed Central PMCID:
PMC5367386.
Analysis of cytochrome P450 CYP119 ligand-dependent conformational dynamics by two-dimensional NMR and X-ray crystallography.
J Biol Chem.
2015 Apr 17;290(16):10000-17. doi: 10.1074/jbc.M114.627935. Epub 2015 Feb 10. PubMed PMID:
25670859; PubMed Central PMCID:
PMC4400317.
Cytochrome P450 Enzyme Metabolites in Lead Discovery and Development.
Annu Rep Med Chem.
2014;49:347-359. doi: 10.1016/B978-0-12-800167-7.00022-5. PubMed PMID:
25797999; PubMed Central PMCID:
PMC4365796.
Role of protein-protein interactions in cytochrome P450-mediated drug metabolism and toxicity.
Chem Res Toxicol.
2014 Sep 15;27(9):1474-86. doi: 10.1021/tx500203s. Epub 2014 Aug 29. Review. PubMed PMID:
25133307; PubMed Central PMCID:
PMC4164225.
Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake.
Drug Metab Dispos.
2014 Jun;42(6):990-5. doi: 10.1124/dmd.113.055095. Epub 2014 Mar 31. PubMed PMID:
24688079; PubMed Central PMCID:
PMC4014663.
Role of cysteine residues in heme binding to human heme oxygenase-2 elucidated by two-dimensional NMR spectroscopy.
J Biol Chem.
2012 Oct 12;287(42):35181-35191. doi: 10.1074/jbc.M112.378042. Epub 2012 Aug 24. PubMed PMID:
22923613; PubMed Central PMCID:
PMC3471713.
Mouse strain-dependent caspase activation during acetaminophen hepatotoxicity does not result in apoptosis or modulation of inflammation.
Toxicol Appl Pharmacol.
2011 Dec 15;257(3):449-58. doi: 10.1016/j.taap.2011.10.006. Epub 2011 Oct 14. PubMed PMID:
22023962; PubMed Central PMCID:
PMC3226924.
Active-site residues move independently from the rest of the protein in a 200 ns molecular dynamics simulation of cytochrome P450 CYP119.
Arch Biochem Biophys.
2011 May 15;509(2):127-32. doi: 10.1016/j.abb.2011.02.020. Epub 2011 Feb 26. PubMed PMID:
21356195; PubMed Central PMCID:
PMC3085956.
Two-dimensional NMR and all-atom molecular dynamics of cytochrome P450 CYP119 reveal hidden conformational substates.
J Biol Chem.
2010 Mar 26;285(13):9594-9603. doi: 10.1074/jbc.M109.087593. Epub 2010 Jan 22. PubMed PMID:
20097757; PubMed Central PMCID:
PMC2843209.
Ligand-induced conformational heterogeneity of cytochrome P450 CYP119 identified by 2D NMR spectroscopy with the unnatural amino acid (13)C-p-methoxyphenylalanine.
J Am Chem Soc.
2008 Dec 3;130(48):16168-9. doi: 10.1021/ja8071463. PubMed PMID:
18998650; PubMed Central PMCID:
PMC2645923.
Spectral resolution of a second binding site for Nile Red on cytochrome P4503A4.
Arch Biochem Biophys.
2008 Jun 1;474(1):198-204. doi: 10.1016/j.abb.2008.03.017. Epub 2008 Mar 25. PubMed PMID:
18395506; PubMed Central PMCID:
PMC2474736.
Nile Red is a fluorescent allosteric substrate of cytochrome P450 3A4.
Biochemistry.
2008 Jan 15;47(2):509-16. doi: 10.1021/bi7013807. Epub 2007 Dec 20. PubMed PMID:
18092806.
Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus.
Cancer Epidemiol Biomarkers Prev.
2007 Nov;16(11):2387-95. doi: 10.1158/1055-9965.EPI-06-0986. PubMed PMID:
18006928.
Time-resolved fluorescence studies of heterotropic ligand binding to cytochrome P450 3A4.
Biochemistry.
2006 Oct 10;45(40):12204-15. doi: 10.1021/bi060083h. PubMed PMID:
17014074.
Cysteine 98 in CYP3A4 contributes to conformational integrity required for P450 interaction with CYP reductase.
Arch Biochem Biophys.
2006 Oct 1;454(1):42-54. doi: 10.1016/j.abb.2006.08.003. Epub 2006 Aug 22. PubMed PMID:
16959210; PubMed Central PMCID:
PMC2001172.
NMR studies of ligand binding to P450(eryF) provides insight into the mechanism of cooperativity.
Biochemistry.
2006 Feb 14;45(6):1673-84. doi: 10.1021/bi0518895. PubMed PMID:
16460014.
Probing the CYP3A4 active site by cysteine scanning mutagenesis and photoaffinity labeling.
Arch Biochem Biophys.
2005 Dec 15;444(2):100-11. doi: 10.1016/j.abb.2005.09.010. Epub 2005 Oct 21. PubMed PMID:
16289363.
Antisense oligonucleotides containing modified bases inhibit in vitro translation of Leishmania amazonensis mRNAs by invading the mini-exon hairpin.
J Biol Chem.
1999 Mar 19;274(12):8191-8. doi: 10.1074/jbc.274.12.8191. PubMed PMID:
10075723.
Factors influencing the extent and selectivity of alkylation within triplexes by reactive G/A motif oligonucleotides.
Nucleic Acids Res.
1997 Oct 15;25(20):4123-31. doi: 10.1093/nar/25.20.4123. PubMed PMID:
9321668; PubMed Central PMCID:
PMC146991.
What would you like to do?